Clinical Trials
9
Active:8
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury
Phase 2
Completed
- Conditions
- Myocardial IschemiaCoronary DiseaseMyocardial Infarction
- Interventions
- Procedure: Percutaneous coronary intervention
- First Posted Date
- 2006-05-17
- Last Posted Date
- 2007-12-04
- Lead Sponsor
- Fibrex Medical Research & Development GmbH
- Target Recruit Count
- 234
- Registration Number
- NCT00326976
- Locations
- 🇦🇹
Allgemeines Krankenhaus Wien, Vienna, Austria
🇦🇹Wilhelminen-Spital, Vienna, Austria
🇧🇪Academisch Ziekenhuis van de vrije Universiteit, Brussels, Belgium
News
No news found